Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

1779

Actual shortage: 173 (10%)
Anticipated shortage: 4 (0%)
Avoided shortage: 7 (0%)
Resolved: 1595 (90%)

Discontinuation Reports

343

To be discontinued: 21 (6%)
Discontinued: 322 (94%)
Reversed: 0 (0%)

Late reports

120 (6%)

Overdue reports

22 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-OXYCODONE CR 60MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-18 2019-02-08 69921
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-19 2019-07-17 70146
APO-DESVENLAFAXINE 50MG TABLET (EXTENDED-RELEASE) Resolved 2019-01-03 2019-01-17 71118
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2019-01-03 2019-05-17 71136
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2019-01-15 2019-02-21 72363
APO-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Resolved 2019-01-30 2020-11-03 74033
APO-DESVENLAFAXINE 50MG TABLET (EXTENDED-RELEASE) Resolved 2019-02-21 2019-04-05 76582
APO-METFORMIN ER 1000MG TABLET (EXTENDED-RELEASE) Resolved 2019-02-24 2019-04-15 76726
APO-QUETIAPINE XR 150MG TABLET (EXTENDED-RELEASE) Resolved 2019-02-24 2020-11-03 76735
APO-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Resolved 2019-02-24 2020-11-03 76740
APO-DESVENLAFAXINE 100MG TABLET (EXTENDED-RELEASE) Resolved 2019-04-10 2019-05-14 80926
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2019-04-24 2019-06-21 82337
APO-DESVENLAFAXINE 50MG TABLET (EXTENDED-RELEASE) Resolved 2019-04-30 2019-05-13 82837
APO-METFORMIN ER 1000MG TABLET (EXTENDED-RELEASE) Resolved 2019-05-08 2019-06-24 83504
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2019-05-15 2019-06-24 84159
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2019-06-05 2019-06-21 85619
APO-METFORMIN ER 1000MG TABLET (EXTENDED-RELEASE) Resolved 2019-07-03 2019-08-03 88336
APO-DESVENLAFAXINE 50MG TABLET (EXTENDED-RELEASE) Resolved 2019-08-21 2019-09-16 92019
APO-METFORMIN ER 1000MG TABLET (EXTENDED-RELEASE) Resolved 2019-08-21 2019-08-30 92026
APO-METOPROLOL SR 100MG TABLET (EXTENDED-RELEASE) Resolved 2019-08-21 2019-10-08 92029

Showing 1701 to 1720 of 1779

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-VALSARTAN Discontinued 2019-01-03 2019-01-03 71032
APO-VALSARTAN Discontinued 2019-01-03 2019-01-03 71035
APO-VALSARTAN Discontinued 2019-01-03 2019-01-03 71038
APO-VALSARTAN/HCTZ Discontinued 2019-01-03 2019-01-03 71044
APO-VALSARTAN/HCTZ Discontinued 2019-01-03 2019-01-03 71048
APO-VALSARTAN/HCTZ Discontinued 2019-01-03 2019-01-03 71051
APO-VALSARTAN/HCTZ Discontinued 2019-01-03 2019-01-03 71057
ACID CONTROL Discontinued 2019-01-04 2019-01-04 71198
APO-RIZATRIPTAN RPD Discontinued 2019-01-04 2019-04-04 71334
APO PEN VK Discontinued 2019-03-08 2019-03-08 78141
APO PEN VK Discontinued 2019-03-08 2019-03-08 78144
APO-ALMOTRIPTAN Discontinued 2019-05-13 2019-05-13 83971
APO-ALMOTRIPTAN Discontinued 2019-05-13 2019-05-13 83976
APO-AMOXI CLAV 250MG/62.5MG PER 5ML Discontinued 2019-05-13 2019-05-13 83981
APO-AMOXI CLAV Discontinued 2019-05-17 2019-05-18 84392
APO-CEFPROZIL Discontinued 2019-05-17 2019-05-18 84396
APO-CEFPROZIL Discontinued 2019-06-12 2019-06-12 86542
APO-CIPROFLOX Discontinued 2019-06-12 2019-06-12 86547
APO-EXEMESTANE Discontinued 2019-06-12 2019-06-12 86552
APO-GEMFIBROZIL CAP 300MG USP Discontinued 2019-06-12 2019-06-12 86557

Showing 21 to 40 of 343